Showing 3021-3030 of 8740 results for "".
Access Is Everything
https://practicaldermatology.com/topics/practice-management/access-is-everything/23942/The Safe Step Act of 2023 seeks to rein in fail-first policies and protect patients.Close Up With Mikkel Østergaard, MD, PhD, DMSc
https://practicaldermatology.com/topics/close-up/close-up-with-mikkel-ostergaard-md-phd-dmsc/23941/Close Up with Eric F. Bernstein, MD
https://practicaldermatology.com/topics/close-up/close-up-with-eric-f-bernstein-md/23928/Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-3/23917/Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-45/23890/2023: The Year Ahead for the M&A and Capital Markets
https://practicaldermatology.com/topics/practice-management/2023-the-year-ahead-for-the-ma-and-capital-markets/23883/How would a recession impact your dermatology practice?How May Biosimilars Affect the Treatment of Psoriasis?
https://practicaldermatology.com/topics/psoriasis/how-may-biosimilars-affect-the-treatment-of-psoriasis/23867/The answer depends on several factors.Redefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.Who Is the Expert?
https://practicaldermatology.com/topics/practice-management/who-is-the-expert/23739/